These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 35930181)

  • 1. Predictors of "brain fog" 1 year after COVID-19 disease.
    Cristillo V; Pilotto A; Piccinelli SC; Gipponi S; Leonardi M; Bezzi M; Padovani A
    Neurol Sci; 2022 Oct; 43(10):5795-5797. PubMed ID: 35930181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Biopsychosocial Approach to Persistent Post-COVID-19 Fatigue and Cognitive Complaints: Results of the Prospective Multicenter NeNeSCo Study.
    Klinkhammer S; Duits AA; Deckers K; Horn J; Slooter AJC; Verwijk E; van Heugten CM; Visser-Meily JMA;
    Arch Phys Med Rehabil; 2024 May; 105(5):826-834. PubMed ID: 38228250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for brain fog: Is the montreal cognitive assessment an effective screening tool for neurocognitive complaints post-COVID-19?
    Lynch S; Ferrando SJ; Dornbush R; Shahar S; Smiley A; Klepacz L
    Gen Hosp Psychiatry; 2022; 78():80-86. PubMed ID: 35930974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Demographic and social determinants of cognitive dysfunction following hospitalization for COVID-19.
    Valdes E; Fuchs B; Morrison C; Charvet L; Lewis A; Thawani S; Balcer L; Galetta SL; Wisniewski T; Frontera JA
    J Neurol Sci; 2022 Jul; 438():120146. PubMed ID: 35031121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unraveling brain fog in post-COVID syndrome: Relationship between subjective cognitive complaints and cognitive function, fatigue, and neuropsychiatric symptoms.
    Delgado-Alonso C; Díez-Cirarda M; Pagán J; Pérez-Izquierdo C; Oliver-Mas S; Fernández-Romero L; Martínez-Petit Á; Valles-Salgado M; Gil-Moreno MJ; Yus M; Matías-Guiu J; Ayala JL; Matias-Guiu JA
    Eur J Neurol; 2023 Oct; ():. PubMed ID: 37797297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive Clinical Characterisation of Brain Fog in Adults Reporting Long COVID Symptoms.
    Jennings G; Monaghan A; Xue F; Duggan E; Romero-Ortuño R
    J Clin Med; 2022 Jun; 11(12):. PubMed ID: 35743516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 infection is associated with self-reported post-acute neuropsychological symptoms within six months of follow-up.
    Andronescu LR; Richard SA; Scher AI; Lindholm DA; Mende K; Ganesan A; Huprikar N; Lalani T; Smith A; Mody RM; Jones MU; Bazan SE; Colombo RE; Colombo CJ; Ewers E; Larson DT; Maves RC; Berjohn CM; Maldonado CJ; English C; Sanchez Edwards M; Rozman JS; Rusiecki J; Byrne C; Simons MP; Tribble D; Burgess TH; Pollett SD; Agan BK
    PLoS One; 2024; 19(4):e0297481. PubMed ID: 38626117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Premorbid vulnerability and disease severity impact on Long-COVID cognitive impairment.
    Cristillo V; Pilotto A; Cotti Piccinelli S; Bonzi G; Canale A; Gipponi S; Bezzi M; Leonardi M; Padovani A;
    Aging Clin Exp Res; 2022 Jan; 34(1):257-260. PubMed ID: 35014002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatigue, perceived stigma, self-reported cognitive deficits and psychological morbidity in patients recovered from COVID-19 infection.
    Grover S; Sahoo S; Mishra E; Gill KS; Mehra A; Nehra R; Suman A; Bhalla A; Puri GD
    Asian J Psychiatr; 2021 Oct; 64():102815. PubMed ID: 34455354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring risk factors for persistent neurocognitive sequelae after hospitalization for COVID-19.
    Ch'en PY; Gold LS; Lu Q; Ye T; Andrews JS; Patel P
    Ann Clin Transl Neurol; 2023 Jul; 10(7):1200-1208. PubMed ID: 37265172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between brain fog, cardiac injury, and quality of life at work after hospitalization due to COVID-19.
    Chatys-Bogacka Ż; Mazurkiewicz I; Słowik J; Słowik A; Drabik L; Wnuk M
    Med Pr; 2024 Mar; 75(1):3-17. PubMed ID: 38523497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of SARS-CoV-2 Infection With Psychological Distress, Psychotropic Prescribing, Fatigue, and Sleep Problems Among UK Primary Care Patients.
    Abel KM; Carr MJ; Ashcroft DM; Chalder T; Chew-Graham CA; Hope H; Kapur N; McManus S; Steeg S; Webb RT; Pierce M
    JAMA Netw Open; 2021 Nov; 4(11):e2134803. PubMed ID: 34783824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trajectories of Neurologic Recovery 12 Months After Hospitalization for COVID-19: A Prospective Longitudinal Study.
    Frontera JA; Yang D; Medicherla C; Baskharoun S; Bauman K; Bell L; Bhagat D; Bondi S; Chervinsky A; Dygert L; Fuchs B; Gratch D; Hasanaj L; Horng J; Huang J; Jauregui R; Ji Y; Kahn DE; Koch E; Lin J; Liu S; Olivera A; Rosenthal J; Snyder T; Stainman R; Talmasov D; Thomas B; Valdes E; Zhou T; Zhu Y; Lewis A; Lord AS; Melmed K; Meropol SB; Thawani S; Troxel AB; Yaghi S; Balcer LJ; Wisniewski T; Galetta S
    Neurology; 2022 Jul; 99(1):e33-e45. PubMed ID: 35314503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurological and Psychiatric Manifestations of Post-COVID-19 Conditions.
    Jung YH; Ha EH; Park J; Choe KW; Lee WJ; Jo DH
    J Korean Med Sci; 2023 Mar; 38(11):e83. PubMed ID: 36942392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effectiveness of the anxiolytic Anvifen in the treatment of post-COVID brain fog].
    Esin RG; Khayrullin IK; Esin OR; Malova LA; Alimbekova LR
    Zh Nevrol Psikhiatr Im S S Korsakova; 2022; 122(8):101-105. PubMed ID: 36036410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Life stressors significantly impact long-term outcomes and post-acute symptoms 12-months after COVID-19 hospitalization.
    Frontera JA; Sabadia S; Yang D; de Havenon A; Yaghi S; Lewis A; Lord AS; Melmed K; Thawani S; Balcer LJ; Wisniewski T; Galetta SL;
    J Neurol Sci; 2022 Dec; 443():120487. PubMed ID: 36379135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain Fog and Fatigue following COVID-19 Infection: An Exploratory Study of Patient Experiences of Long COVID.
    Chasco EE; Dukes K; Jones D; Comellas AP; Hoffman RM; Garg A
    Int J Environ Res Public Health; 2022 Nov; 19(23):. PubMed ID: 36497573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measuring cognitive impairment in young adults with polysubstance use disorder with MoCA or BRIEF-A - The significance of psychiatric symptoms.
    Hagen E; Sømhovd M; Hesse M; Arnevik EA; Erga AH
    J Subst Abuse Treat; 2019 Feb; 97():21-27. PubMed ID: 30577896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 cognitive deficits after respiratory assistance in the subacute phase: A COVID-rehabilitation unit experience.
    Alemanno F; Houdayer E; Parma A; Spina A; Del Forno A; Scatolini A; Angelone S; Brugliera L; Tettamanti A; Beretta L; Iannaccone S
    PLoS One; 2021; 16(2):e0246590. PubMed ID: 33556127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyposmia Is Associated with Reduced Cognitive Function in COVID-19: First Preliminary Results.
    Pirker-Kees A; Platho-Elwischger K; Hafner S; Redlich K; Baumgartner C
    Dement Geriatr Cogn Disord; 2021; 50(1):68-73. PubMed ID: 33853062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.